title: Gold nanoparticles production using reactor and cyclotron based methods in assessment of (196,198)Au production yields by (197)Au neutron absorption for therapeutic purposes.
abstract: Medical nano-gold radioisotopes is produced regularly using high-flux nuclear reactors, and an accelerator-driven neutron activator can turn out higher yield of (197)Au(n,γ)(196,198)Au reactions. Here, nano-gold production via radiative/neutron capture was investigated using irradiated Tehran Research Reactor flux and also simulated proton beam of Karaj cyclotron in Iran. (197)Au nano-solution, including 20nm shaped spherical gold and water, was irradiated under Tehran reactor flux at 2.5E+13n/cm(2)/s for (196,198)Au activity and production yield estimations. Meanwhile, the yield was examined using 30MeV proton beam of Karaj cyclotron via simulated new neutron activator containing beryllium target, bismuth moderator around the target, and also PbF2 reflector enclosed the moderator region. Transmutation in (197)Au nano-solution samples were explored at 15 and 25cm distances from the target. The neutron flux behavior inside the water and bismuth moderators was investigated for nano-gold particles transmutation. The transport of fast neutrons inside bismuth material as heavy nuclei with a lesser lethargy can be contributed in enhanced nano-gold transmutation with long duration time than the water moderator in reactor-based method. Cyclotron-driven production of βeta-emitting radioisotopes for brachytherapy applications can complete the nano-gold production technology as a safer approach as compared to the reactor-based method.
authors: Gerash Research Institute-Mother Home of Gerash, Cellular and Molecular Gerash Research Center, Gerash School of Medical Science, Shiraz University of Medical Sciences, P.O. BOX: 7441955666, Shiraz, Iran. Electronic address: abkhorshidi@yahoo.com.
authors: Abdollah
authors: A
authors: Khorshidi
mesh_terms: D001918:Brachytherapy / Q000379:methods; D017357:Cyclotrons; D006046:Gold / Q000737:chemistry* / Q000627:therapeutic use; D006801:Humans; D053768:Metal Nanoparticles / Q000737:chemistry* / Q000627:therapeutic use; D009502:Neutrons; D011868:Radioisotopes / Q000737:chemistry* / Q000627:therapeutic use
chemical_list: D011868:Radioisotopes; D006046:Gold
keywords: Gold nanoparticles production; MCNPX code; Reactor/cyclotron method; Saturation yield